Broad implementation of lung cancer screening is complex, and the National Cancer Policy Forum held a workshop, “Implementation of Lung Cancer Screening,” to examine the opportunities and challenges involved in developing effective lung cancer screening programs in clinical practice.
At the workshop, experts discussed the current evidence base for lung cancer screening, best practices for screening programs, incorporation of shared decision-making and smoking cessation services in screening, and assessment of patient outcomes, quality, and value in lung cancer screening programs; and research needs that could improve implementation efforts. These proceedings chronicle the presentations and discussions at the workshop. A free PDF version of the workshop proceedings is available once you have created a free National Academy Press account.
Explore More

Cancer Statistics Center
The ACS’ Cancer Statistics Center website gives the user an opportunity to explore, interact with, and share cancer statistics.

Updates Regarding Biomarker Testing For Non–Small Cell Lung Cancer: Considerations From The National Lung Cancer Roundtable
Updates Regarding Biomarker Testing For Non–Small Cell Lung Cancer: Considerations From The National Lung Cancer Roundtable

Accelerating Uptake of Lung Cancer Screening Summit Executive Summary
The American Cancer Society National Lung Cancer Roundtable (ACS NLCRT) held its inaugural summit on Accelerating Uptake of Lung Cancer Screening on July 19-20, 2022, in Washington, DC. Increasing lung cancer screening has long been a priority of the NLCRT and its members. The goal of the summit was to accelerate the uptake of lung cancer screening by creating a shared understanding of the current state of screening, identifying key challenges and barriers, and developing and prioritizing strategies to build a comprehensive framework that engages key partners with actionable recommendations.